Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023.
Bodriagova O, Previs RA, Gaba L, Shankar A, Vidal L, Saini KS. Bodriagova O, et al. Among authors: previs ra. Oncol Ther. 2023 Dec;11(4):397-409. doi: 10.1007/s40487-023-00244-5. Epub 2023 Sep 15. Oncol Ther. 2023. PMID: 37715082 Free PMC article. No abstract available.
RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
Severson E, Achyut BR, Nesline M, Pabla S, Previs RA, Kannan G, Chenn A, Zhang S, Klein R, Conroy J, Sausen M, Sathyan P, Saini KS, Ghosh A, Jensen TJ, Reddy P, Ramkissoon SH. Severson E, et al. Among authors: previs ra. J Mol Diagn. 2023 Jul;25(7):454-466. doi: 10.1016/j.jmoldx.2023.03.011. Epub 2023 May 8. J Mol Diagn. 2023. PMID: 37164276 Free article.
Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors.
Verner EL, Jackson JB, Severson E, Valkenburg KC, Greer AE, Riley DR, Sausen M, Maddox C, McGregor PM 3rd, Karandikar A, Hastings SB, Previs RA, Reddy VP, Jensen TJ, Ramkissoon SH. Verner EL, et al. Among authors: previs ra. J Mol Diagn. 2023 Jul;25(7):477-489. doi: 10.1016/j.jmoldx.2023.03.008. Epub 2023 Apr 15. J Mol Diagn. 2023. PMID: 37068734 Free article.
Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers.
Vidal L, Dlamini Z, Qian S, Rishi P, Karmo M, Joglekar N, Abedin S, Previs RA, Orbegoso C, Joshi C, Azim HA, Karkaria H, Harris M, Mehrotra R, Berraondo M, Werutsky G, Gupta S, Niikura N, Chico I, Saini KS. Vidal L, et al. Among authors: previs ra. ESMO Open. 2024 May 7;9(5):103373. doi: 10.1016/j.esmoop.2024.103373. Online ahead of print. ESMO Open. 2024. PMID: 38718705 Free article. Review.
OX40/OX40 ligand and its role in precision immune oncology.
Thapa B, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Previs RA, Conroy JM, DePietro P, Pabla S, Kurzrock R. Thapa B, et al. Among authors: previs ra. Cancer Metastasis Rev. 2024 Mar 25. doi: 10.1007/s10555-024-10184-9. Online ahead of print. Cancer Metastasis Rev. 2024. PMID: 38526805 Review.
The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer.
Nesline MK, Subbiah V, Previs RA, Strickland KC, Ko H, DePietro P, Biorn MD, Cooper M, Wu N, Conroy J, Pabla S, Zhang S, Wallen ZD, Sathyan P, Saini K, Eisenberg M, Caveney B, Severson EA, Ramkissoon S. Nesline MK, et al. Among authors: previs ra. Oncol Ther. 2024 Mar 19. doi: 10.1007/s40487-024-00270-x. Online ahead of print. Oncol Ther. 2024. PMID: 38502426 Free article.
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer.
Seager RJ, Senosain MF, Van Roey E, Gao S, DePietro P, Nesline MK, Dash DP, Zhang S, Ko H, Hastings SB, Strickland KC, Previs RA, Jensen TJ, Eisenberg M, Caveney BJ, Severson EA, Ramkissoon S, Conroy JM, Pabla S. Seager RJ, et al. Among authors: previs ra. J Transl Med. 2024 Feb 7;22(1):141. doi: 10.1186/s12967-024-04918-0. J Transl Med. 2024. PMID: 38326843 Free PMC article.
86 results